How do we define “castration” in men on androgen deprivation therapy?
نویسندگان
چکیده
منابع مشابه
How do we define "difficult" patients?
Why do our patients have to meet our needs? The image I have is not someone who is difficult, but rather someone who is doing the best she can in her own life and is not willing to bend to fit our expectations. R eceiving a referral for a patient who is described as being difficult is not uncommon for me, particularly after many years of working in what some might call “non-mainstream” areas. H...
متن کاملHow Do We Define Cure of Diabetes?
The mission of the American Diabetes Association is “to prevent and cure diabetes and to improve the lives of all people affected by diabetes.” Increasingly, scientific and medical articles (1) and commentaries (2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes. Several approved or experimental treatments for type 1 and type 2 diabetes (e.g., pancreas or ...
متن کاملScreening for osteoporosis in men receiving androgen deprivation therapy.
To the Editor: Prostate cancer is the most common cancer in men. One in 2 men with prostate cancer is expected to receive androgen deprivation therapy (ADT). Use of ADT is associated with accelerated bone loss and an increased risk of fractures. To better characterize fracture risk and optimize bone health, a bone mineral density (BMD) test has been recommended prior to ADT initiation since 200...
متن کاملCardiovascular Disease Risk Factors: How Relevant in African Men With Prostate Cancer Receiving Androgen-Deprivation Therapy?
PURPOSE Cardiovascular disease risk factors have been associated with androgen-deprivation therapy (ADT) in white and Hispanic populations. It is therefore relevant to determine if there exists a relationship between these parameters in the African population. PATIENTS AND METHODS The design of the study was cross sectional. Prostate-specific antigen concentration, waist circumference, body m...
متن کاملAndrogen deprivation therapy.
© TouCh MEdiCal MEdia 2014 This review describes strategies for producing castrate levels of testosterone in men with androgen-sensitive prostate cancer (PC) and the associated toxicities, with particular focus on the re-emergence and potential benefits of parenteral estrogen. In the developed world, PC is the commonest malignancy and second commonest cause of cancer death affecting men. Its in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Asian Journal of Andrology
سال: 2020
ISSN: 1008-682X
DOI: 10.4103/aja.aja_139_19